Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bb355ee2fb4eaef1b0a175dc377eaa9a8> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bb355ee2fb4eaef1b0a175dc377eaa9a8 NCIT_P378 "NCI" @default.
- Bb355ee2fb4eaef1b0a175dc377eaa9a8 type Axiom @default.
- Bb355ee2fb4eaef1b0a175dc377eaa9a8 annotatedProperty IAO_0000115 @default.
- Bb355ee2fb4eaef1b0a175dc377eaa9a8 annotatedSource NCIT_C91732 @default.
- Bb355ee2fb4eaef1b0a175dc377eaa9a8 annotatedTarget "An agent targeting the phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in the PI3K/mTOR signaling pathway, with potential antineoplastic activity. Upon intravenous administration, gedatolisib inhibits both PI3K and mTOR kinases, which may result in apoptosis and growth inhibition of cancer cells overexpressing PI3K/mTOR. Activation of the PI3K/mTOR pathway promotes cell growth, survival, and resistance to chemotherapy and radiotherapy; mTOR, a serine/threonine kinase downstream of PI3K, may also be activated independent of PI3K." @default.